[Calcium lonazolac and blood loss in users of intrauterine devices. Preliminary report].
D000328:Adult; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D008796:Metrorrhagia / Q000188:drug therapy* / Q000209:etiology; D011448:Prostaglandin Antagonists / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D014592:Uterine Hemorrhage / Q000188:drug therapy* / Q000209:etiology
D011448:Prostaglandin Antagonists; D011720:Pyrazoles; C017472:lonazolac
Lonazolac cálcico y pérdida sanguínea en usuarias de dispositivos intrauterinos. Informe preliminar.